May 28-29, T-CURX invited to present at 7th International CGT China Summit in Suzhou, China

T-CURX CEO, Ulf Grawunder, will introduce T-CURX vision to develop non-viral CAR-T therapies at the 7th international CGT China Summit in Suzhou, China

T-CURX CEO, Ulf Grawunder, PhD, is an invited speaker at the 7th international Cell and Gene Therapy Summit China (CGCS) taking place from May 28-29, 2026 at the congress center of the Shangri-La Hotel in Suzhou, China. The annual CGCS conference brings together about 1'500 cell and gene therapy experts from China and international biotechs as well as academic centers, mainly from the APAC region. T-CURX CEO, Ulf Grawunder, PhD will present T-CURX ambitions to democratize CAR-T therapies for patients globally, by leveraging non-viral transposon-based CAR-T manufacturing for ex vivo CAR-T pipeline products and also new in vivo CAR-T strategies. Ulf's presentation will take place at 2:00 p.m. Meeting Room3 in the stream "Frontiers in Immune Cell Therapy".

For more information on this congress, please visit the conference's web-site at:

https://www.bagevent.com/event/9156802